Platinum-doublet Chemotherapy and Nivolumab for the Treatment of Subjects With Neuroendocrine Neoplasms (NENs) of the Gastroenteropancreatic (GEP) Tract or of Unknown (UK) Origin.
Clinical trial NCT03980925 · COMPLETED
Trial details
- NCT number
- NCT03980925
- Sponsor
- Grupo Espanol de Tumores Neuroendocrinos
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-11
- Primary completion
- 2023-02-13
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.